These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 22154368)
1. Agonist trigger: what is the best approach? Agonist trigger and low dose hCG. Humaidan P Fertil Steril; 2012 Mar; 97(3):529-30. PubMed ID: 22154368 [TBL] [Abstract][Full Text] [Related]
2. Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support. Engmann L; Benadiva C Fertil Steril; 2012 Mar; 97(3):531-3. PubMed ID: 22245529 [TBL] [Abstract][Full Text] [Related]
4. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Garcia-Velasco JA Fertil Steril; 2012 Mar; 97(3):527-8. PubMed ID: 22222191 [TBL] [Abstract][Full Text] [Related]
5. Agonist and antagonist coast. Aboulghar M Fertil Steril; 2012 Mar; 97(3):523-6. PubMed ID: 22265033 [TBL] [Abstract][Full Text] [Related]
6. Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin. Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Hudson C Fertil Steril; 2011 Jun; 95(8):2715-7. PubMed ID: 21550042 [TBL] [Abstract][Full Text] [Related]
7. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928 [TBL] [Abstract][Full Text] [Related]
8. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports. Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932 [TBL] [Abstract][Full Text] [Related]
9. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114 [TBL] [Abstract][Full Text] [Related]
10. HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept. Haas J; Kedem A; Machtinger R; Dar S; Hourvitz A; Yerushalmi G; Orvieto R J Ovarian Res; 2014 Apr; 7():35. PubMed ID: 24694069 [TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269 [TBL] [Abstract][Full Text] [Related]
12. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development. Krause BT; Ohlinger R Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065 [TBL] [Abstract][Full Text] [Related]
15. 'GnRH agonist trigger: looking for the coin under the lamp post?'. Kol S Hum Reprod; 2006 May; 21(5):1328; author reply 1328-9. PubMed ID: 16611976 [No Abstract] [Full Text] [Related]
16. GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at 'freeze-all strategy'. Ling LP; Phoon JW; Lau MS; Chan JK; Viardot-Foucault V; Tan TY; Nadarajah S; Tan HH Reprod Biomed Online; 2014 Sep; 29(3):392-4. PubMed ID: 25042608 [TBL] [Abstract][Full Text] [Related]
17. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome. Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601 [TBL] [Abstract][Full Text] [Related]
18. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Huber M; Hadziosmanovic N; Berglund L; Holte J Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964 [TBL] [Abstract][Full Text] [Related]
19. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support. Castillo JC; Dolz M; Bienvenido E; Abad L; Casañ EM; Bonilla-Musoles F Reprod Biomed Online; 2010 Feb; 20(2):175-81. PubMed ID: 20113955 [TBL] [Abstract][Full Text] [Related]
20. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Griffin D; Benadiva C; Kummer N; Budinetz T; Nulsen J; Engmann L Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]